Post
Podcast #1: Doing Digital Deals in Life Sciences | Corporate Culture
Welcome to the first of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them …
Alkermes begins Phase II trial of ALKS 2680 for narcolepsy type 1
Alkermes has commenced the Vibrance-1 Phase II clinical trial to evaluate ALKS 2680 in patients with narcolepsy type 1 (NT1). ALKS …
CalciMedica enrols last patient for Phase IIb acute pancreatitis trial
CalciMedica has announced the completion of patient enrollment for its Phase IIb CARPO clinical trial, which is evaluating the efficacy …
Gain touts positive Phase I results for Parkinson’s therapy
Gain Therapeutics’ GT-02287 was found to be safe and tolerable in the Phase I trial of the therapy in healthy …
EXO Biologics hopes to gain conditional marketing from Phase I/II BPD trial
EXO Biologics is hoping to receive conditional market approval from the European Medicines Agency (EMA) for its bronchopulmonary dysplasia (BPD) …
Gain touts positive Phase I results for Parkinson’s therapy
Gain Therapeutics’ GT-02287 was found to be safe and tolerable in the Phase I trial of the therapy in healthy …
EXO Biologics hopes to gain conditional marketing from Phase I/II BPD trial
EXO Biologics is hoping to receive conditional market approval from the European Medicines Agency (EMA) for its bronchopulmonary dysplasia (BPD) …
Lykos concludes European Phase II study for PTSD
Lykos Therapeutics has completed a European Phase II study (MP18) evaluating midomafetamine (MDMA) capsules for post-traumatic stress disorder (PTSD). MP18 is …
CureVac initiates H5N1 avian influenza vaccine study
CureVac has commenced the first phase of a combined Phase I/II clinical trial of a pre-pandemic vaccine candidate targeting the …
“Intentional effort” needed from sponsors to achieve diversity in oncology clinical trials
Representatives from the biopharma industry agreed that “intentional effort” is required from sponsors to ensure diverse populations are reached in …
World Immunization Week 2024: mRNA vaccines hold potential in multiple disease areas
World Immunization Week occurs annually during the last week of April. The campaign aims to highlight the collective action needed …
Alto Neuroscience reveals positive ALTO-101 Phase I trial results
Alto Neuroscience has reported positive results from its Phase I clinical trial of the PDE4 inhibitor, ALTO-101, for treating cognitive …
Response Pharmaceuticals’ RDX-002 meets primary endpoint in Phase Ib trial
Response Pharmaceuticals announced that the Phase Ib clinical trial yielded positive results for RDX-002, a novel treatment aimed at preventing …
Novartis and MMV’s Coartem shows promise in infants with Phase II/III data
Novartis and Medicines for Malaria Venture (MMV) have reported positive data from the Phase II/III CALINA trial of Coartem (artemether …
Alzheimer’s trial doses patients with stem cell treatment directly to brain
California-based Regeneration Biomedical has dosed the first patient has been dosed in a first-in-human trial of its autologous stem cell …